Fujita Health University · Faculty of Medicine / Graduate School of Medicine · 准教授

Research keywordscisplatin nephrotoxicity prevention・oncology symptom care・chemotherapy induced neutropenia・colorectal cancer pharmacotherapy・acute kidney injury risk・adverse drug event database

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial.2026 · JMIR research protocols
• Comparison of standard and biweekly trifluridine/tipiracil plus bevacizumab regimens in advanced or recurrent colorectal cancer: a retrospective study.2025 · Japanese journal of clinical oncology
• Frequency of Acute Kidney Injury After the Initiation of Vitamin D Receptor Activators: A Multicenter Retrospective Observational Study2025 · Clinical Drug Investigation
• Concomitant use of sivelestat sodium hydrate and antithrombotic drugs worsens the treatment outcome of patients with acute respiratory distress syndrome and suppression of fibrinolysis: a single-center, retrospective study.2025 · Fujita medical journal

• 炎症糸球体での好中球細胞外トラップ形成と組織傷害におけるトランスグルタミナーゼ2の役割解明2025 · 科学研究費助成事業
• グリコカリクスに着目した抗悪性腫瘍薬による血小板減少症予測モデルの構築2025 · 科学研究費助成事業
• 切れ目のないポリファーマシー対策を提供するための薬剤師間の情報連携の推進に資する研究2023 · 厚生労働科学研究費
• ライフスタイルに着目した慢性腎臓病（CKD）対策に資する研究2023 · 厚生労働科学研究費

• Official profile